Emagix
EMAGIX is an early stage biomedical company that has developed an algorithm-driven approach for diagnosis of retinal and brain vascular injury.
There is an emerging consensus of the key role of leaky blood vessels in the development of a wide range of ophthalmic and neurologic disorders. With the growth in the number of people affected by diabetes, Emagix is focused on preventing the devastating consequence of visual loss.